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CASE REPORT
Cat scratch disease (CSD) is a common cause of
subacute regional, self-limited lymphadenitis in
children, who usually have contact with a cat or
kitten.1 The most common etiologic agent of CSD
is thought to be Bartonella henselae, a fastidious,
slow-growing, Gram-negative bacillus.2,3 Typical
CSD usually presents with a papule at the site of
the scratch and regional lymphadenopathy.1–3
Systemic CSD is often associated with a prolonged
fever and microabscesses in the liver and/or
spleen.4 There have been several reports of hepato-
splenic granulomas caused by B. henselae.5–10 We
report a healthy 9-year-old girl with systemic CSD
caused by B. henselae.
Case Report
A previously healthy 9-year-old aboriginal girl had
a persistent fever of 38–39°C for about 17 days ac-
companied by left lower back pain, weight loss and
rheadache. She visited a local hospital 6 days afte
ythe onset of her illness and was presumptivel
treated for acute bronchitis and urinary tract infec-
tion for 11 days. However, the fever persisted, and
she was referred to our hospital for evaluation. The
family had three dogs in the house and the neigh-
bors had some domestic pigs and chickens. She
had slept with a cat at night, which was kept out-
side during the day. She also frequently ate raw fish.
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On admission, body temperature was 37.8°C,
blood pressure was 98/75 mmHg, heart rate was
95/minute, and respiratory rate was 24/minute.
Neither peripheral lymphadenopathy nor hepato-
splenomegaly was detected. On physical examina-
tion, there were no specific dermatologic findings,
including any eschar, scratch or bite wound by 
insects or animals. White blood cell count was
9260/mm3, with 58% neutrophils and 32% 
lymphocytes. The erythrocyte sedimentation rate
during the first hour was 104 mm. Urinalysis was
negative and renal function was within normal
limits. Antibody screening tests to cytomegalovirus,
Epstein–Barr virus and Mycoplasma pneumoniae as
well as Weil–Felix test, Widal test, rheumatic factor
and anti-nuclear antibody were all negative. Bac-
terial and fungal cultures of the bone marrow and
blood yielded no growth. A purified protein deriv-
ative skin test was negative. On admission, chest
fX-ray was normal. She had a daily spiking fever o
38–39°C in the afternoon or early morning with-
out relative bradycardia. On day 5, she complained
of left upper quadrant abdominal pain, headache,
nausea and vomiting. Abdominal computed tomo-
graphy (CT) showed multiple tiny, hypodense
nodular lesions in the spleen and both kidneys
twithout para-aortic lymph node enlargemen
(Figure 1A and B). Brain CT was normal. Cerebral
spinal fluid studies and serum antibody titers to
Rickettsia typhi and Rickettsia burnetii were negative.
Follow-up abdominal echogram and abdominal
CT 8 days later showed progression of the nodu-
lar lesions in the spleen and both kidneys (Figure
y1C and D). On day 21, exploratory laparotom
with partial splenectomy revealed multiple soft,
rwhitish-tan lesions on the surfaces of the live
and spleen (Figure 2A and B). Pathologic exami-
nation with hematoxylin and eosin stain of the
A B
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iF gure 1. Contrast-enhanced abdominal computed tomography (CT) showing multiple small hypodense nodular lesions
(arrows) within the: (A) spleen, and (B) both kidneys. Follow-up CT 8 days later showing the progression of hypodense
nodular lesions (arrows) in the (C) spleen, and (D) kidneys.
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splenic tissue showed necrotizing granulomatous
inflammatory changes with central necrosis sur-
rounded by epitheloid cells and a few occasional
Langhans’ giant cells (Figure 2C and D). Stains
for fungus and acid-fast microorganisms were
negative.
Serum antibody titer against B. henselae was
greater than 1:2048 by indirect immunofluo-
rescence antibody test (IFA). This technique
employed a volume of 30 μL of suspension 
containing B. henselae (ATCC 49882)11 infected
cells coated on Teflon-printed slides (Electron
Microscopy Science, USA). The serum was serially
diluted from 1:32 to 1:512 by twofold dilutions
using phosphate buffered saline (PBS, pH 7.4;
with 10% skimmed milk). Thirty microliters of 
diluted serum was added to each well. Fluorescein-
labeled goat antihuman immunoglobulin G
(Kirkegaard & Perry Laboratories Inc., Gaithersburg,
MD, USA) in 1:400 PBS dilution was then applied
cto each well. The intensity of the bacillus-specifi
fluorescence was scored subjectively from 1 to 4
by fluorescence microscope (magnification, ×400). 
A fluorescence score ≥2 at the dilution of 1:64 
was considered to be positive.11
Polymerase chain reaction (PCR) was used to
test the presence of B. henselae (Figure 3). Two
sets of primers, PBH-1, PBH-2,12 Hensela-A and
Hensela-B, deduced from ridD, ribC and ribE
genes of B. henselae y , were used to identif
B. henselae. PCR was carried out in a DNA ther-
mal cycler (GeneAmp PCR System 9700; Perkin-
Elmer, Foster City, CA, USA). The amplicon
was sequenced using the ABI PRISM BigDye
tTerminator Cycle Sequencing Ready Reaction Ki







iF gure 2. ( ) h h f l h f f h l ( h d) d l ( ) ( )A, B  W itis -tan so t esions on t e sur ace o  t e iver arrow ea  an  sp een arrows  at surgery. C  Low-
power view of the spleen biopsy showing necrotizing granulomatous inflammation with central necrosis (hematoxylin &
eosin, 40×). (D) High-power view showing central necrosis surrounded by epithelioid cells and Langhans’ giant cells
(arrowheads) (hematoxylin & eosin, 200×).
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Biosystems, Foster City, CA, USA). A positive result
was indicated by the appearance of a single band
of 345 bp in the specimens. Sequence analysis of
this amplicon showed a totally identical genome
to that of B. henselae.
The patient gradually improved during 4 weeks
of tetracycline and rifampin treatment and was
discharged on day 28 with continued prescription
of these antibiotics. Follow-up abdominal CT scan
showed resolution of the liver, spleen and kidney
lesions 5 months later. Immune studies (including
immunoglobins, C3, C4 and CH50 levels) per-
formed 2 months later were within normal limits.
Discussion
Systemic CSD is a clinical entity caused by B.
henselae, which manifests with necrotizing gran-
ulomas in visceral organs. This microorganism
was first identified as the cause of this disease 
in 1983, having eluded detection for 50 years.
Initially, Afipia felis was thought to be the
etiology; however, subsequent studies failed to
confirm a correlation. During the 1990s, the
fastidious Gram-negative bacillus Rochalimaea
henselae was initially identified, but on the basis
of genomic sequence analysis, it was subse-
quently reclassified in the genus Bartonella.13
CSD occurs at all ages, but most of the patients
are aged under 10 years, with a median of 8.6
years. Lien et al14 reported a male gender predo-
minance (54–60%). The organisms apparently
spread from the site of inoculation, usually a cat-
inflicted injury.6 The most common clinical pres-
entation of typical CSD is lymphadenopathy, often
involving the nodes that drain inoculation sites in
the neck, axillary, epitrochlear or inguinal areas.
The most plausible mode of the spread of infec-
tion to the liver and spleen is hematogenous.15
A patient with hepatic lesions was first described
in 1985.4 Systemic B. henselae infection has been
reported in immunocompetent children who
had prolonged fever and multiple granulomatous
lesions in the liver and spleen.4–10 Associated acute
glomerulonephritis has also been reported.16,17
In addition to liver and spleen lesions, our pa-
tient had renal microabscesses, a manifestation
not previously reported in the English literature.
Prolonged fever associated with abdominal
pain, weight loss, chills, headache and myalgia
care the most common symptoms of systemi
CSD.10 Abdominal pain has been suggested to
be an important symptom implicating visceral
involvement.8 Physical findings such as hepato-
ymegaly, splenomegaly and lymphadenopath
were reported in CSD.9,10 Peripheral lympha-
denitis may be a diagnostic clue of CSD; how-
fever, only one-fourth of the patients in a series o
19 patients with hepatosplenic involvement had
lymphadenitis.10
Abdominal ultrasound is helpful in the evalua-
tion of systemic CSD. The findings of multiple-
hypoechogenic lesions in the liver and/or spleen
are suggestive of the diagnosis in the appropriate
clinical setting.9 Hepatic and splenic granulomas














































iF gure 3. ff tion o  A 345-bp amplicon showing positive identi ica Bartonella
henselae.
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scattered throughout the liver and spleen.18,19
Definitive diagnosis of systemic CSD, however,
requires invasive investigation, including liver or
spleen biopsy.9,19 The diagnosis of Bartonella in-
fection must be established by one or more means:
histopathologic examination of biopsy speci-
mens,20 serologic evaluation,11,21,22 microbiologic
culture and/or use of PCR to detect DNA in tis-
sue specimens.22–24 Culture of the organism is
not practical for clinical diagnosis and the tradi-
tional cat scratch skin test is no longer used and
has been supplanted by sensitive serologic tests.25
Different serologic tests (including IFA or EIA)
vary in sensitivities and specificities because of the
timing of the B. henselae IgG and IgM response
and cross-reaction with antibodies to B. quitana.14
Sander et al found IFA to be the most frequent
and reliable serologic test.26 PCR is a sensitive
method for detecting Bartonella DNA which can
even identify the species and genotypes by exploit-
ing minor sequence differences. This permits dif-
ferentiation between B. henselae and B. quintana
and makes PCR the best method to confirm clin-
ically, serologically or histologically suspected
diagnosis of CSD.27–29 Our patient had a positive
antibody to B. henselae and a positive PCR result.
There is limited evidence of a beneficial effect
of antibiotic treatment in disseminated B. henselae
infection in the immunocompetent host.3 A re-
view of treatment outcome found that rifampicin,
trimethoprim-sulfamethoxazole (TMP-SMZ) and
ciprofloxacin appear to be effective.30 Rifampicin
has been reported to give a favorable clinical
response in children with hepatosplenic CSD.10
Another study found dramatic response to treat-
ment with rifampicin and doxycycline.19 Our 
patient’s symptoms resolved after treatment with
rifampicin and tetracycline, and the lesions on
CT scan disappeared. Although we did not ob-
tain actual tissue confirmation of B. henselae in
the renal lesions, the fact that they disappeared
at the same time as the hepatic and splenic le-
sions strongly suggests that they were manifesta-
tions of the systemic infection.
In conclusion, systemic CSD should be in-
cluded in the differential diagnosis of children
with fever of unknown origin, abdominal pain
Aand elevated erythrocyte sedimentation rate. 
key to the diagnosis is a history of contact with
a cat or kitten. Imaging studies may suggest the
diagnosis, and specific serology may confirm it,
perhaps avoiding the need for biopsy.
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